CamilaMasiasMD

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Overview of Dr. Masias

I am a board certified hematologist and medical oncologist. I completed my training at the Ohio State University - James Comprehensive Cancer Center, where I also completed a Masters in Public Health with an emphasis in clinical and translational research. I devote my clinical practice to the field of classical hematology, and have a research interest in thrombotic microangiopathies and platelet disorders.

Office
8900 N Kendall Dr
Miami, FL 33176
Book by Phone+1(786) 698-1522

Fax+1 305-279-7778

Education & Training

The Ohio State University Master of Public Health, Clinical and Translational Research , 2017 - 2019
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2015 - 2018
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2011 - 2014
Cayetano Heredia UniversityClass of 2008

Certifications & Licensure

FL State Medical License 2019 - 2026
OH State Medical License 2015 - 2021
NY State Medical License 2014 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Clinical Research Training Insitute American Society of Hematology, 2019
Outstanding Clinical Care Award The Ohio State University, hematology and Oncology fellowship, 2018

Publications & Presentations

PubMed

15 citations
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Di...
Paul L den Exter, Scott C Woller, Helia Robert-Ebadi, Camila Masias, Pierre-Emmanuel Morange
Journal of Thrombosis and Haemostasis. 2022-08-01
16 citations
Race, rituximab, and relapse in TTP.
Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian
Blood. 2022-09-22
40 citations
The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis
Camila Masias, Spero R. Cataland
Blood. 2018-08-30

Journal Articles

The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis
Spero R Cataland, Camila Masias, Blood

Abstracts/Posters

Severely Deficient ADAMTS13 Activity Predicts Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Pregnancy
Camila Masias, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

A Pilot Study on Biomarkers of Vascular Injury in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019